Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines. Learn more.

Current Research Studies

An Open-Label Study with Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy

Perampanel_Epilep

Phase: II
Clinicaltrials.gov ID: NCT04015141

What is the goal of the study?

This is a multicenter, open-label single-arm study in children age 1 month to less than 18 years with a pediatric epileptic syndrome (Cohort 1) or children age 1 month to less than 2 years with partial-onset seizures (POS) (Cohort 2). The study will consist of a Core Study and Extension Phase

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Jason Lockrow
Study Team Member: Jacqueline Lee-Eng, [email protected]

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.